Financhill
Sell
39

SNN Quote, Financials, Valuation and Earnings

Last price:
$33.06
Seasonality move :
6.32%
Day range:
$32.93 - $33.25
52-week range:
$23.69 - $38.79
Dividend yield:
2.3%
P/E ratio:
29.54x
P/S ratio:
2.44x
P/B ratio:
3.50x
Volume:
553K
Avg. volume:
509.6K
1-year change:
33.68%
Market cap:
$14.2B
Revenue:
$5.8B
EPS (TTM):
$1.13

Analysts' Opinion

  • Consensus Rating
    Smith & Nephew plc has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $36.63, Smith & Nephew plc has an estimated upside of 10.53% from its current price of $33.14.
  • Price Target Downside
    According to analysts, the lowest downside price target is $34.00 representing 100% downside risk from its current price of $33.14.

Fair Value

  • According to the consensus of 4 analysts, Smith & Nephew plc has 10.53% upside to fair value with a price target of $36.63 per share.

SNN vs. S&P 500

  • Over the past 5 trading days, Smith & Nephew plc has overperformed the S&P 500 by 1.36% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Smith & Nephew plc does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Smith & Nephew plc has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Smith & Nephew plc reported revenues of --.

Earnings Growth

  • Smith & Nephew plc earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Smith & Nephew plc reported earnings per share of --.
Enterprise value:
15.8B
EV / Invested capital:
--
Price / LTM sales:
2.44x
EV / EBIT:
17.27x
EV / Revenue:
2.64x
PEG ratio (5yr expected):
0.24x
EV / Free cash flow:
19.72x
Price / Operating cash flow:
18.24x
Enterprise value / EBITDA:
10.10x
Gross Profit (TTM):
$4.2B
Return On Assets:
4.66%
Net Income Margin (TTM):
8.27%
Return On Equity:
9.2%
Return On Invested Capital:
5.7%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2012-12-31 2013-12-31 2014-12-31 2013-12-31 2014-12-31
Income Statement
Revenue -- -- -- $1.2B $1.2B
Gross Profit -- -- -- $890.1M $911M
Operating Income -- -- -- $271.5M $314M
EBITDA -- -- -- $358.3M $433M
Diluted EPS -- -- -- $0.36 --
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets $4.4B $3.8B $3.9B $4.5B $4.6B
Total Assets $10.9B $10.1B $9.8B $10.5B $10.7B
Current Liabilities $2.1B $2.1B $1.8B $1.8B $1.5B
Total Liabilities $5.6B $4.7B $4.6B $5.3B $5.2B
Total Equity $5.3B $5.4B $5.2B $5.2B $5.5B
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2012-12-31 2013-12-31 2014-12-31 2013-12-31 2014-12-31
Cash Flow Statement
Cash Flow Operations -- -- -- $321M $302M
Cash From Investing -- -- -- -$199M $85M
Cash From Financing -- -- -- -$112M -$426M
Free Cash Flow -- -- -- -- --
SNN
Sector
Market Cap
$14.2B
$27.9M
Price % of 52-Week High
85.43%
50.56%
Dividend Yield
2.3%
0%
Shareholder Yield
2.44%
-1.55%
1-Year Price Total Return
33.68%
-17.49%
Beta (5-Year)
0.635
0.516
Dividend yield:
2.3%
Annualized payout:
$0.75
Payout ratio:
-66.63%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $32.87
200-day SMA
Buy
Level $32.12
Bollinger Bands (100)
Sell
Level 33.36 - 37.22
Chaikin Money Flow
Buy
Level 411K
20-day SMA
Buy
Level $32.86
Relative Strength Index (RSI14)
Buy
Level 50.28
ADX Line
Buy
Level 31.61
Williams %R
Neutral
Level -29.8701
50-day SMA
Sell
Level $33.91
MACD (12, 26)
Buy
Level 9.15
25-day Aroon Oscillator
Sell
Level -20
On Balance Volume
Neutral
Level 2.4M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.1511)
Buy
CA Score (Annual)
Level (0.2612)
Buy
Beneish M-Score (Annual)
Level (-2.7631)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.3798)
Buy
Piotroski F Score (Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Stock Forecast FAQ

In the current month, SNN has received 1 Buy ratings 3 Hold ratings, and 0 Sell ratings. The SNN average analyst price target in the past 3 months is $36.63.

  • Where Will Smith & Nephew plc Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Smith & Nephew plc share price will rise to $36.63 per share over the next 12 months.

  • What Do Analysts Say About Smith & Nephew plc?

    Analysts are divided on their view about Smith & Nephew plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Smith & Nephew plc is a Sell and believe this share price will drop from its current level to $34.00.

  • What Is Smith & Nephew plc's Price Target?

    The price target for Smith & Nephew plc over the next 1-year time period is forecast to be $36.63 according to 4 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is SNN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Smith & Nephew plc is a Hold. 3 of 4 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of SNN?

    You can purchase shares of Smith & Nephew plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Smith & Nephew plc shares.

  • What Is The Smith & Nephew plc Share Price Today?

    Smith & Nephew plc was last trading at $33.06 per share. This represents the most recent stock quote for Smith & Nephew plc. Yesterday, Smith & Nephew plc closed at $33.14 per share.

  • How To Buy Smith & Nephew plc Stock Online?

    In order to purchase Smith & Nephew plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
14
SMX alert for Dec 30

SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.

Buy
71
ZCSH alert for Dec 30

Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.

Buy
69
GDXU alert for Dec 30

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock